dimethyl sulfoxide has been researched along with Metabolic Syndrome in 2 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, T | 1 |
| Yamamoto, J | 1 |
| Iwasaki, S | 1 |
| Asaba, H | 1 |
| Hamura, H | 1 |
| Ikeda, Y | 1 |
| Watanabe, M | 1 |
| Magoori, K | 1 |
| Ioka, RX | 1 |
| Tachibana, K | 1 |
| Watanabe, Y | 1 |
| Uchiyama, Y | 1 |
| Sumi, K | 1 |
| Iguchi, H | 1 |
| Ito, S | 1 |
| Doi, T | 1 |
| Hamakubo, T | 1 |
| Naito, M | 1 |
| Auwerx, J | 1 |
| Yanagisawa, M | 1 |
| Kodama, T | 1 |
| Sakai, J | 1 |
| Mundt, S | 1 |
| Solly, K | 1 |
| Thieringer, R | 1 |
| Hermanowski-Vosatka, A | 1 |
2 other studies available for dimethyl sulfoxide and Metabolic Syndrome
| Article | Year |
|---|---|
Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome.
Topics: Animals; Dimethyl Sulfoxide; Enzymes; Fatty Acids, Nonesterified; Insulin Resistance; Lipid Metaboli | 2003 |
Development and application of a scintillation proximity assay (SPA) for identification of selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 11-beta-Hydroxysteroid Dehydrogenase Type 2; Animals; A | 2005 |